Available downloads
All links are direct pdf downloads of ECHO session presentations unless specified.
Important!
These files are provided for information only and are not intended to replace the clinical judgement of a practitioner. They should not be used alone to guide individual patient care.
Search
« First
‹ Previous
1
2
34
5
6
Next ›
Last »
High dose methadone to LAIB transfers
Session date: 10/03/2021
*This presentation contains outdated information and has been removed. Lookout for an update soon*
Session date: 10/03/2021
*This presentation contains outdated information and has been removed. Lookout for an update soon*
PDFOverview of pharmacotherapies – methadone, buprenorphine incl. LAIB
Session date: 03/02/2021
Session 3 of our foundation series
Session date: 03/02/2021
Session 3 of our foundation series
PDFOpioid use disorder – assessment and treatment
Session date: 27/01/2021
Session 2 of our foundation series
Session date: 27/01/2021
Session 2 of our foundation series
PDFReducing risk of opioid-use-disorder
Session date: 04/11/2020
An overview of identifying and mitigating the risks of developing problematic opioid use.
Session date: 04/11/2020
An overview of identifying and mitigating the risks of developing problematic opioid use.
PDFPerceptions and experiences of pain and symptom management for people with cancer who use illicit drugs
Session date: 21/10/2020
Reports on a small study on the perceptions and experiences of people with cancer who use illicit drugs and their treating clinicians.
Session date: 21/10/2020
Reports on a small study on the perceptions and experiences of people with cancer who use illicit drugs and their treating clinicians.
PDFSexual health
Session date: 16/09/2020
A discussion of some aspects of sexual health and substance use
Session date: 16/09/2020
A discussion of some aspects of sexual health and substance use
PDFHydromorphone as OAT
Session date: 19/08/2020
A discussion of the evidence for the use of hydromorphone as opioid agonist therapy.
Session date: 19/08/2020
A discussion of the evidence for the use of hydromorphone as opioid agonist therapy.
PDFResources available for PTSD
Session date: 10/06/2020
National and Victorian resources available for post-traumatic stress disorder survivors and clinicians, in metropolitan and rural areas and online,
« First
‹ Previous
1
2
34
5
6
Next ›
Last »
Session date: 10/06/2020
National and Victorian resources available for post-traumatic stress disorder survivors and clinicians, in metropolitan and rural areas and online,